Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|November 18, 2024
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based studyRoger S McIntyre, Angela T H Kwan
Clinical Nutrition (Edinburgh, Scotland)|March 21, 2026
Muscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational studyAngela T H Kwan, Moiz Lakhani, Roger S McIntyre
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 9, 2025
Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigationsSophie Li, Sami George Sabbah, Angela T H Kwan, et al.
American Journal of Ophthalmology|March 20, 2025
Drugs Associated With Floppy Iris Syndrome: A Real-World Population-Based StudyMoiz Lakhani, Angela T H Kwan, Andrew Mihalache, et al.
The American Journal of Psychiatry|January 1, 2024
Psychotropic Drug-Related Weight Gain and Its TreatmentRoger S McIntyre, Angela T H Kwan, Joshua D Rosenblat, et al.
Expert Opinion on Drug Safety|June 17, 2024
The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)Roger S McIntyre, Rodrigo B Mansur, Joshua D Rosenblat, et al.
Pageof 10